Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the european study: Molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)

  1. Haberichter, S.L.
  2. Castaman, G.
  3. Budde, U.
  4. Peake, I.
  5. Goodeve, A.
  6. Rodeghiero, F.
  7. Federici, A.B.
  8. Batlle, J.
  9. Meyer, D.
  10. Mazurier, C.
  11. Goudemand, J.
  12. Eikenboom, J.
  13. Schneppenheim, R.
  14. Ingerslev, J.
  15. Vorlova, Z.
  16. Habart, D.
  17. Holmberg, L.
  18. Lethagen, S.
  19. Pasi, J.
  20. Hill, F.G.H.
  21. Montgomery, R.R.
Revista:
Blood

ISSN: 1528-0020 0006-4971

Ano de publicación: 2008

Volume: 111

Número: 10

Páxinas: 4979-4985

Tipo: Artigo

DOI: 10.1182/BLOOD-2007-09-110940 GOOGLE SCHOLAR